Comparison of LTA in Patients with Bleeding Disorder of Unknown Cause and Healthy Blood Donors – Now on RPTH Journal
RPTH Journal shared a post on LinkedIn:
“A new study reassesses guideline-recommended agonist concentrations for light transmission aggregometry (LTA). By comparing individuals with bleeding disorder of unknown cause to healthy donors, the work from Lena-Theresa Fanenbruck highlights important considerations for interpreting LTA results in clinical practice.
Read the full article in RPTH for the full analysis and implications for testing standards.”
Ttile: Comparison of light transmission aggregometry in patients with bleeding disorder of unknown cause and healthy blood donors
Authors: Lena-Theresa Fanenbruck, Michael Metze, Maria Weise, Martin Federbusch, Roland Siegemund, Martin Reinhard Henschler, Annelie Siegemund, Sirak Petros, Christian Pfrepper
Get the latest insights on Hemostasis Today.
-
Feb 19, 2026, 16:01Honoring Black Pioneers in Hematology During Black History Month – ASH
-
Feb 19, 2026, 15:16Irina Pahlevanyan: Global Leaders on Courage, Trust, and the True Purpose of Fundraising
-
Feb 19, 2026, 15:12Stéphanie Forté: Transition Readiness in Youth With Sickle Cell Disease
-
Feb 19, 2026, 15:08Tagreed Alkaltham: Strengthening Blood Inventory Governance Through RFID Technology
-
Feb 19, 2026, 14:59Başak Taburoğlu Yılmaz: Improving Diagnosis and Care for Women With Bleeding Disorders
-
Feb 19, 2026, 14:59Munira Borhany: Moving Beyond Stereotypes in the Diagnosis of Bleeding Disorders
-
Feb 19, 2026, 14:56Flora Peyvandi: Personalized VWF Dosing Revolutionizes Surgery in VWD
-
Feb 19, 2026, 14:54Michela Mazzon: The Molecular Trigger Behind the COVID19 Vaccines-Associated ITT
-
Feb 19, 2026, 14:42Luca Palombi: Real-Time Assessment of Venous Hemodynamics During Movement With DUS